文献速递妇产影像泌尿生殖MR

子宫内膜癌淋巴结转移:基于最佳子集回归的预测模型

Nodal infiltration in endometrial cancer: a prediction model using best subset regression.
PubMed 文献 · Eur Radiol · 2023-10-26

本回顾性双中心研究纳入364例子宫内膜癌患者,利用10项既定危险因素通过最佳子集回归构建区域淋巴结转移和腹主动脉旁淋巴结转移的术前预测模型,并做外部验证。含MRI的模型外部验证AUC分别为0.85和0.86,不含MRI的模型AUC分别为0.79和0.87,作者认为可能避免不必要的淋巴结清扫。

要点

  • 区域淋巴结转移最终模型含盆腔淋巴结≥6 mm、MRI深肌层浸润、CA125、腹主动脉旁淋巴结≥6 mm和活检。
  • 区域淋巴结转移模型外部验证AUC为0.85(95%CI 0.77-0.92),腹主动脉旁淋巴结转移模型为0.86(0.75-0.94)。
  • 不含MRI的区域淋巴结转移模型AUC为0.79(0.68-0.89),腹主动脉旁淋巴结转移模型为0.87(0.76-0.96)。

核心结论

  • 最佳子集回归结合交叉验证构建的预测模型对子宫内膜癌淋巴结转移具有较高诊断性能,作者认为可能避免不必要的淋巴结清扫。

研究设计与样本

  • 回顾性双中心研究,共纳入364例子宫内膜癌患者,其中253例用于模型开发、111例用于外部验证。

关键影像表现/征象

  • 区域淋巴结转移最终模型包含盆腔淋巴结≥6 mm、MRI深肌层浸润、CA125、腹主动脉旁淋巴结≥6 mm和活检(按β值排序)。
  • 腹主动脉旁淋巴结转移最终模型包含深肌层浸润、腹主动脉旁淋巴结、盆腔淋巴结和CA125(按β值排序)。

诊断标准与关键数值

  • 区域淋巴结转移模型外部验证AUC为0.85(95%CI 0.77-0.92)。
  • 腹主动脉旁淋巴结转移模型外部验证AUC为0.86(95%CI 0.75-0.94)。
  • 不含MRI的区域淋巴结转移模型AUC为0.79(95%CI 0.68-0.89)。
  • 不含MRI的腹主动脉旁淋巴结转移模型AUC为0.87(95%CI 0.76-0.96)。

临床应用与阅片要点

  • 作者认为将常规临床信息输入模型可便捷获得淋巴结转移和腹主动脉旁淋巴结转移的预测风险,有助于优化淋巴结清扫决策和个体化治疗。
  • 作者指出基于大小标准的淋巴结转移诊断性能较低,结合其他临床信息可提高诊断性能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To build preoperative prediction models with and without MRI for regional lymph node metastasis (r-LNM, pelvic and/or para-aortic LNM (PENM/PANM)) and for PANM in endometrial cancer using established risk factors.

METHODS: In this retrospective two-center study, 364 patients with endometrial cancer were included: 253 in the model development and 111 in the external validation. For r-LNM and PANM, respectively, best subset regression with ten-time fivefold cross validation was conducted using ten established risk factors (4 clinical and 6 imaging factors). Models with the top 10 percentile of area under the curve (AUC) and with the fewest variables in the model development were subjected to the external validation (11 and 4 candidates, respectively, for r-LNM and PANM). Then, the models with the highest AUC were selected as the final models. Models without MRI findings were developed similarly, assuming the cases where MRI was not available.

RESULTS: The final r-LNM model consisted of pelvic lymph node (PEN) ≥ 6 mm, deep myometrial invasion (DMI) on MRI, CA125, para-aortic lymph node (PAN) ≥ 6 mm, and biopsy; PANM model consisted of DMI, PAN, PEN, and CA125 (in order of correlation coefficient β values). The AUCs were 0.85 (95%CI: 0.77-0.92) and 0.86 (0.75-0.94) for the external validation, respectively. The model without MRI for r-LNM and PANM showed AUC of 0.79 (0.68-0.89) and 0.87 (0.76-0.96), respectively.

CONCLUSIONS: The prediction models created by best subset regression with cross validation showed high diagnostic performance for predicting LNM in endometrial cancer, which may avoid unnecessary lymphadenectomies.

CLINICAL RELEVANCE STATEMENT: The prediction risks of lymph node metastasis (LNM) and para-aortic LNM can be easily obtained for all patients with endometrial cancer by inputting the conventional clinical information into our models. They help in the decision-making for optimal lymphadenectomy and personalized treatment.

KEY POINTS: •Diagnostic performance of lymph node metastases (LNM) in endometrial cancer is low based on size criteria and can be improved by combining with other clinical information. •The optimized logistic regression model for regional LNM consists of lymph node ≥ 6 mm, deep myometrial invasion, cancer antigen-125, and biopsy, showing high diagnostic performance. •Our model predicts the preoperative risk of LNM, which may avoid unnecessary lymphadenectomies.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Matsumoto YK, Himoto Y, Nishio M, et al. Nodal infiltration in endometrial cancer: a prediction model using best subset regression. Eur Radiol. 2023. PMID: 37882835. doi:10.1007/s00330-023-10310-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。